Whimsical Sculptures Wickedly Inspired
Multi-media sculptures created by artist Jessica Dvergsten designed to capture the imagination and tell their own unique story from the natural world, the land of fantasy, science fiction, and the macabre. These narratives are woven into each piece using both handmade and found objects.
Giving Back Through Art Appreciation
As part of an ongoing commitment I've made to giving back to my global community, 10% of all sales will be donated directly to a cause that is near and dear to my heart. That's from all sales, 365 days of the year!
What cause you ask?
As a cancer survivor, who is married to a cancer survivor, I can tell you first hand about how important state of the art medical care is. I chose to be treated at MD Anderson because of their superior reputation for treating adult cancers. The research that was developed there was used successfully to identify the genomic type of cancer I had and enabled my doctors to institute of coarse of action that allows me to be here today.
As a research hospital, philanthropic gifts help make possible this lifesaving work. In 2014, donors generously gave 239 million in cash, planned gifts and pledges.
I want us to be part of that!
*U.S. News & World Report’s “Best Hospitals” survey ranks MD Anderson the nation’s top hospital for cancer care. MD Anderson has been ranked the nation’s leading cancer hospital for 11 of the past 14 years. The institution has been named one of the nation’s top two hospitals for cancer care every year since the survey began in 1990.
*A few of MD Anderson's achievements....
- The institution’s faculty is one of the most esteemed in the nation, including nine Institute of Medicine members, three National Academy of Sciences members, four Academy of Arts and Sciences fellows and 32 American Association for the Advancement of Science fellows.
- The Moon Shots Program is dramatically accelerating the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. So far, the program has received almost $213 million in private philanthropic commitments.
- Investigators in the Breast and Ovarian Cancer Moon Shot created an MD Anderson algorithm for determining when ovarian cancer patients should have surgery. This systematic approach has more than tripled the rate of complete surgical removal of patients’ tumors, from 25% to more than 80%.
- GP2, a new breast cancer vaccine in development at MD Anderson, has been shown to reduce recurrence rates by 57%. High-risk patients who were given the vaccine after completion of the immunotherapy drug trastuzumab had no cancer recurrences.
- Developed genomic tests that predict the likelihood of a patient’s breast cancer recurring after surgery without additional treatment and the cancer’s vulnerability to chemotherapy or hormone therapy.
- Developed mammography technology and showed that mammography can detect breast cancer at early, highly curable stages, leading to adoption of standardized screening mammography.
- The Institute for Applied Cancer Science identifies and validates new cancer targets, converts the scientific knowledge into new cancer drugs and advances the novel agents into innovative clinical trials. A team of IACS drug development experts identified and developed IACS-10759, which blocks the conversion of nutrients into the energy that fuels cancer cells.
Year To Date